Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Clinical trial NCT04308395 · TERMINATED
Trial details
- NCT number
- NCT04308395
- Sponsor
- Sol-Gel Technologies, Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2021-07-14
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.